徐放性薬物送達システムのグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Sustained Release Drug Delivery Systems Market Insights, Forecast to 2028

• レポートコード：QY2203B10774
• 出版社/出版日：QYResearch / 2022年3月
• レポート形態：英文、PDF、129ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療装置

• 販売価格（消費税別）

Single User	￥686,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,029,000 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,372,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

新型コロナウイルス感染症のパンデミックにより、世界の徐放性薬物送達システムの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に徐放性薬物送達システムの世界市場のxxx％を占める「非生分解性インプラント」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
中国の徐放性薬物送達システムの市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの徐放性薬物送達システム市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの徐放性薬物送達システム市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

徐放性薬物送達システムのグローバル主要メーカーには、West Pharmaceutical Services、Cirtec Medical、Balda、Lubrizol、Beckman Coulter、Scios、Noven Pharmaceuticals、Raritan Pharmaceuticals、Parker Hannifin、Nitto Avecia Pharma Services、KV Pharmaceutical、Equashield、Shire Laboratories、Powder Systems、B. Braun OEM Division、Pharmaco-Kinesis、Foresee、Bayer、Catalent、Pfizerなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

徐放性薬物送達システム市場は、種類と用途によって区分されます。世界の徐放性薬物送達システム市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
非生分解性インプラント、生分解性インプラント、マイクロ・ナノパーティクル、リポソーム、ECT

【用途別セグメント】
病院、クリニック、その他

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 徐放性薬物送達システム製品概要
- 種類別市場（非生分解性インプラント、生分解性インプラント、マイクロ・ナノパーティクル、リポソーム、ECT）
- 用途別市場（病院、クリニック、その他）
- 調査の目的
・エグゼクティブサマリー
- 世界の徐放性薬物送達システム販売量予測2017-2028
- 世界の徐放性薬物送達システム売上予測2017-2028
- 徐放性薬物送達システムの地域別販売量
- 徐放性薬物送達システムの地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別徐放性薬物送達システム販売量
- 主要メーカー別徐放性薬物送達システム売上
- 主要メーカー別徐放性薬物送達システム価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（非生分解性インプラント、生分解性インプラント、マイクロ・ナノパーティクル、リポソーム、ECT）
- 徐放性薬物送達システムの種類別販売量
- 徐放性薬物送達システムの種類別売上
- 徐放性薬物送達システムの種類別価格
・用途別市場規模（病院、クリニック、その他）
- 徐放性薬物送達システムの用途別販売量
- 徐放性薬物送達システムの用途別売上
- 徐放性薬物送達システムの用途別価格
・北米市場
- 北米の徐放性薬物送達システム市場規模（種類別、用途別）
- 主要国別の徐放性薬物送達システム市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの徐放性薬物送達システム市場規模（種類別、用途別）
- 主要国別の徐放性薬物送達システム市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の徐放性薬物送達システム市場規模（種類別、用途別）
- 主要国別の徐放性薬物送達システム市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の徐放性薬物送達システム市場規模（種類別、用途別）
- 主要国別の徐放性薬物送達システム市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの徐放性薬物送達システム市場規模（種類別、用途別）
- 主要国別の徐放性薬物送達システム市場規模（トルコ、サウジアラビア）
・企業情報
West Pharmaceutical Services、Cirtec Medical、Balda、Lubrizol、Beckman Coulter、Scios、Noven Pharmaceuticals、Raritan Pharmaceuticals、Parker Hannifin、Nitto Avecia Pharma Services、KV Pharmaceutical、Equashield、Shire Laboratories、Powder Systems、B. Braun OEM Division、Pharmaco-Kinesis、Foresee、Bayer、Catalent、Pfizer
・産業チェーン及び販売チャネル分析
- 徐放性薬物送達システムの産業チェーン分析
- 徐放性薬物送達システムの原材料
- 徐放性薬物送達システムの生産プロセス
- 徐放性薬物送達システムの販売及びマーケティング
- 徐放性薬物送達システムの主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 徐放性薬物送達システムの産業動向
- 徐放性薬物送達システムのマーケットドライバー
- 徐放性薬物送達システムの課題
- 徐放性薬物送達システムの阻害要因
・主な調査結果

Sustained Release Drug Delivery System (SRDDS) is designed to release a drug at a predetermined rate by maintaining a constant drug level for a specific period of time with minimum side effects.
Market Analysis and Insights: Global Sustained Release Drug Delivery Systems Market
Due to the COVID-19 pandemic, the global Sustained Release Drug Delivery Systems market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Nonbiodegradable Implants accounting for % of the Sustained Release Drug Delivery Systems global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospitals segment is altered to an % CAGR throughout this forecast period.
China Sustained Release Drug Delivery Systems market size is valued at US$ million in 2021, while the US and Europe Sustained Release Drug Delivery Systems are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Sustained Release Drug Delivery Systems landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Sustained Release Drug Delivery Systems include West Pharmaceutical Services, Cirtec Medical, Balda, Lubrizol, Beckman Coulter, Scios, Noven Pharmaceuticals, Raritan Pharmaceuticals and Parker Hannifin, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Sustained Release Drug Delivery Systems Scope and Segment
Sustained Release Drug Delivery Systems market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Sustained Release Drug Delivery Systems market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Nonbiodegradable Implants
Biodegradable Implants
Micro- and Nano-Particles
Liposomes
ECT
Segment by Application
Hospitals
Clinics
Others
By Company
West Pharmaceutical Services
Cirtec Medical
Balda
Lubrizol
Beckman Coulter
Scios
Noven Pharmaceuticals
Raritan Pharmaceuticals
Parker Hannifin
Nitto Avecia Pharma Services
KV Pharmaceutical
Equashield
Shire Laboratories
Powder Systems
B. Braun OEM Division
Pharmaco-Kinesis
Foresee
Bayer
Catalent
Pfizer
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

1 Study Coverage
1.1 Sustained Release Drug Delivery Systems Product Introduction
1.2 Market by Type
1.2.1 Global Sustained Release Drug Delivery Systems Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Nonbiodegradable Implants
1.2.3 Biodegradable Implants
1.2.4 Micro- and Nano-Particles
1.2.5 Liposomes
1.2.6 ECT
1.3 Market by Application
1.3.1 Global Sustained Release Drug Delivery Systems Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Sustained Release Drug Delivery Systems Sales Estimates and Forecasts 2017-2028
2.2 Global Sustained Release Drug Delivery Systems Revenue Estimates and Forecasts 2017-2028
2.3 Global Sustained Release Drug Delivery Systems Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Sustained Release Drug Delivery Systems Sales by Region
2.4.1 Global Sustained Release Drug Delivery Systems Sales by Region (2017-2022)
2.4.2 Global Sales Sustained Release Drug Delivery Systems by Region (2023-2028)
2.5 Global Sustained Release Drug Delivery Systems Revenue by Region
2.5.1 Global Sustained Release Drug Delivery Systems Revenue by Region (2017-2022)
2.5.2 Global Sustained Release Drug Delivery Systems Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Sustained Release Drug Delivery Systems Sales by Manufacturers
3.1.1 Global Top Sustained Release Drug Delivery Systems Manufacturers by Sales (2017-2022)
3.1.2 Global Sustained Release Drug Delivery Systems Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Sustained Release Drug Delivery Systems in 2021
3.2 Global Sustained Release Drug Delivery Systems Revenue by Manufacturers
3.2.1 Global Sustained Release Drug Delivery Systems Revenue by Manufacturers (2017-2022)
3.2.2 Global Sustained Release Drug Delivery Systems Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Sustained Release Drug Delivery Systems Revenue in 2021
3.3 Global Sustained Release Drug Delivery Systems Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Sustained Release Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Sustained Release Drug Delivery Systems Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Sustained Release Drug Delivery Systems Sales by Type
4.1.1 Global Sustained Release Drug Delivery Systems Historical Sales by Type (2017-2022)
4.1.2 Global Sustained Release Drug Delivery Systems Forecasted Sales by Type (2023-2028)
4.1.3 Global Sustained Release Drug Delivery Systems Sales Market Share by Type (2017-2028)
4.2 Global Sustained Release Drug Delivery Systems Revenue by Type
4.2.1 Global Sustained Release Drug Delivery Systems Historical Revenue by Type (2017-2022)
4.2.2 Global Sustained Release Drug Delivery Systems Forecasted Revenue by Type (2023-2028)
4.2.3 Global Sustained Release Drug Delivery Systems Revenue Market Share by Type (2017-2028)
4.3 Global Sustained Release Drug Delivery Systems Price by Type
4.3.1 Global Sustained Release Drug Delivery Systems Price by Type (2017-2022)
4.3.2 Global Sustained Release Drug Delivery Systems Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Sustained Release Drug Delivery Systems Sales by Application
5.1.1 Global Sustained Release Drug Delivery Systems Historical Sales by Application (2017-2022)
5.1.2 Global Sustained Release Drug Delivery Systems Forecasted Sales by Application (2023-2028)
5.1.3 Global Sustained Release Drug Delivery Systems Sales Market Share by Application (2017-2028)
5.2 Global Sustained Release Drug Delivery Systems Revenue by Application
5.2.1 Global Sustained Release Drug Delivery Systems Historical Revenue by Application (2017-2022)
5.2.2 Global Sustained Release Drug Delivery Systems Forecasted Revenue by Application (2023-2028)
5.2.3 Global Sustained Release Drug Delivery Systems Revenue Market Share by Application (2017-2028)
5.3 Global Sustained Release Drug Delivery Systems Price by Application
5.3.1 Global Sustained Release Drug Delivery Systems Price by Application (2017-2022)
5.3.2 Global Sustained Release Drug Delivery Systems Price Forecast by Application (2023-2028)
6 North America
6.1 North America Sustained Release Drug Delivery Systems Market Size by Type
6.1.1 North America Sustained Release Drug Delivery Systems Sales by Type (2017-2028)
6.1.2 North America Sustained Release Drug Delivery Systems Revenue by Type (2017-2028)
6.2 North America Sustained Release Drug Delivery Systems Market Size by Application
6.2.1 North America Sustained Release Drug Delivery Systems Sales by Application (2017-2028)
6.2.2 North America Sustained Release Drug Delivery Systems Revenue by Application (2017-2028)
6.3 North America Sustained Release Drug Delivery Systems Market Size by Country
6.3.1 North America Sustained Release Drug Delivery Systems Sales by Country (2017-2028)
6.3.2 North America Sustained Release Drug Delivery Systems Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Sustained Release Drug Delivery Systems Market Size by Type
7.1.1 Europe Sustained Release Drug Delivery Systems Sales by Type (2017-2028)
7.1.2 Europe Sustained Release Drug Delivery Systems Revenue by Type (2017-2028)
7.2 Europe Sustained Release Drug Delivery Systems Market Size by Application
7.2.1 Europe Sustained Release Drug Delivery Systems Sales by Application (2017-2028)
7.2.2 Europe Sustained Release Drug Delivery Systems Revenue by Application (2017-2028)
7.3 Europe Sustained Release Drug Delivery Systems Market Size by Country
7.3.1 Europe Sustained Release Drug Delivery Systems Sales by Country (2017-2028)
7.3.2 Europe Sustained Release Drug Delivery Systems Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Sustained Release Drug Delivery Systems Market Size by Type
8.1.1 Asia Pacific Sustained Release Drug Delivery Systems Sales by Type (2017-2028)
8.1.2 Asia Pacific Sustained Release Drug Delivery Systems Revenue by Type (2017-2028)
8.2 Asia Pacific Sustained Release Drug Delivery Systems Market Size by Application
8.2.1 Asia Pacific Sustained Release Drug Delivery Systems Sales by Application (2017-2028)
8.2.2 Asia Pacific Sustained Release Drug Delivery Systems Revenue by Application (2017-2028)
8.3 Asia Pacific Sustained Release Drug Delivery Systems Market Size by Region
8.3.1 Asia Pacific Sustained Release Drug Delivery Systems Sales by Region (2017-2028)
8.3.2 Asia Pacific Sustained Release Drug Delivery Systems Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Sustained Release Drug Delivery Systems Market Size by Type
9.1.1 Latin America Sustained Release Drug Delivery Systems Sales by Type (2017-2028)
9.1.2 Latin America Sustained Release Drug Delivery Systems Revenue by Type (2017-2028)
9.2 Latin America Sustained Release Drug Delivery Systems Market Size by Application
9.2.1 Latin America Sustained Release Drug Delivery Systems Sales by Application (2017-2028)
9.2.2 Latin America Sustained Release Drug Delivery Systems Revenue by Application (2017-2028)
9.3 Latin America Sustained Release Drug Delivery Systems Market Size by Country
9.3.1 Latin America Sustained Release Drug Delivery Systems Sales by Country (2017-2028)
9.3.2 Latin America Sustained Release Drug Delivery Systems Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Sustained Release Drug Delivery Systems Market Size by Type
10.1.1 Middle East and Africa Sustained Release Drug Delivery Systems Sales by Type (2017-2028)
10.1.2 Middle East and Africa Sustained Release Drug Delivery Systems Revenue by Type (2017-2028)
10.2 Middle East and Africa Sustained Release Drug Delivery Systems Market Size by Application
10.2.1 Middle East and Africa Sustained Release Drug Delivery Systems Sales by Application (2017-2028)
10.2.2 Middle East and Africa Sustained Release Drug Delivery Systems Revenue by Application (2017-2028)
10.3 Middle East and Africa Sustained Release Drug Delivery Systems Market Size by Country
10.3.1 Middle East and Africa Sustained Release Drug Delivery Systems Sales by Country (2017-2028)
10.3.2 Middle East and Africa Sustained Release Drug Delivery Systems Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 West Pharmaceutical Services
11.1.1 West Pharmaceutical Services Corporation Information
11.1.2 West Pharmaceutical Services Overview
11.1.3 West Pharmaceutical Services Sustained Release Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 West Pharmaceutical Services Sustained Release Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 West Pharmaceutical Services Recent Developments
11.2 Cirtec Medical
11.2.1 Cirtec Medical Corporation Information
11.2.2 Cirtec Medical Overview
11.2.3 Cirtec Medical Sustained Release Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Cirtec Medical Sustained Release Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Cirtec Medical Recent Developments
11.3 Balda
11.3.1 Balda Corporation Information
11.3.2 Balda Overview
11.3.3 Balda Sustained Release Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Balda Sustained Release Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Balda Recent Developments
11.4 Lubrizol
11.4.1 Lubrizol Corporation Information
11.4.2 Lubrizol Overview
11.4.3 Lubrizol Sustained Release Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Lubrizol Sustained Release Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Lubrizol Recent Developments
11.5 Beckman Coulter
11.5.1 Beckman Coulter Corporation Information
11.5.2 Beckman Coulter Overview
11.5.3 Beckman Coulter Sustained Release Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Beckman Coulter Sustained Release Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Beckman Coulter Recent Developments
11.6 Scios
11.6.1 Scios Corporation Information
11.6.2 Scios Overview
11.6.3 Scios Sustained Release Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Scios Sustained Release Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Scios Recent Developments
11.7 Noven Pharmaceuticals
11.7.1 Noven Pharmaceuticals Corporation Information
11.7.2 Noven Pharmaceuticals Overview
11.7.3 Noven Pharmaceuticals Sustained Release Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Noven Pharmaceuticals Sustained Release Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Noven Pharmaceuticals Recent Developments
11.8 Raritan Pharmaceuticals
11.8.1 Raritan Pharmaceuticals Corporation Information
11.8.2 Raritan Pharmaceuticals Overview
11.8.3 Raritan Pharmaceuticals Sustained Release Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Raritan Pharmaceuticals Sustained Release Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Raritan Pharmaceuticals Recent Developments
11.9 Parker Hannifin
11.9.1 Parker Hannifin Corporation Information
11.9.2 Parker Hannifin Overview
11.9.3 Parker Hannifin Sustained Release Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Parker Hannifin Sustained Release Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Parker Hannifin Recent Developments
11.10 Nitto Avecia Pharma Services
11.10.1 Nitto Avecia Pharma Services Corporation Information
11.10.2 Nitto Avecia Pharma Services Overview
11.10.3 Nitto Avecia Pharma Services Sustained Release Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Nitto Avecia Pharma Services Sustained Release Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Nitto Avecia Pharma Services Recent Developments
11.11 KV Pharmaceutical
11.11.1 KV Pharmaceutical Corporation Information
11.11.2 KV Pharmaceutical Overview
11.11.3 KV Pharmaceutical Sustained Release Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 KV Pharmaceutical Sustained Release Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 KV Pharmaceutical Recent Developments
11.12 Equashield
11.12.1 Equashield Corporation Information
11.12.2 Equashield Overview
11.12.3 Equashield Sustained Release Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Equashield Sustained Release Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Equashield Recent Developments
11.13 Shire Laboratories
11.13.1 Shire Laboratories Corporation Information
11.13.2 Shire Laboratories Overview
11.13.3 Shire Laboratories Sustained Release Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Shire Laboratories Sustained Release Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Shire Laboratories Recent Developments
11.14 Powder Systems
11.14.1 Powder Systems Corporation Information
11.14.2 Powder Systems Overview
11.14.3 Powder Systems Sustained Release Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Powder Systems Sustained Release Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Powder Systems Recent Developments
11.15 B. Braun OEM Division
11.15.1 B. Braun OEM Division Corporation Information
11.15.2 B. Braun OEM Division Overview
11.15.3 B. Braun OEM Division Sustained Release Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 B. Braun OEM Division Sustained Release Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 B. Braun OEM Division Recent Developments
11.16 Pharmaco-Kinesis
11.16.1 Pharmaco-Kinesis Corporation Information
11.16.2 Pharmaco-Kinesis Overview
11.16.3 Pharmaco-Kinesis Sustained Release Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Pharmaco-Kinesis Sustained Release Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Pharmaco-Kinesis Recent Developments
11.17 Foresee
11.17.1 Foresee Corporation Information
11.17.2 Foresee Overview
11.17.3 Foresee Sustained Release Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Foresee Sustained Release Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Foresee Recent Developments
11.18 Bayer
11.18.1 Bayer Corporation Information
11.18.2 Bayer Overview
11.18.3 Bayer Sustained Release Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 Bayer Sustained Release Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Bayer Recent Developments
11.19 Catalent
11.19.1 Catalent Corporation Information
11.19.2 Catalent Overview
11.19.3 Catalent Sustained Release Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2017-2022)
11.19.4 Catalent Sustained Release Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Catalent Recent Developments
11.20 Pfizer
11.20.1 Pfizer Corporation Information
11.20.2 Pfizer Overview
11.20.3 Pfizer Sustained Release Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2017-2022)
11.20.4 Pfizer Sustained Release Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 Pfizer Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Sustained Release Drug Delivery Systems Industry Chain Analysis
12.2 Sustained Release Drug Delivery Systems Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Sustained Release Drug Delivery Systems Production Mode & Process
12.4 Sustained Release Drug Delivery Systems Sales and Marketing
12.4.1 Sustained Release Drug Delivery Systems Sales Channels
12.4.2 Sustained Release Drug Delivery Systems Distributors
12.5 Sustained Release Drug Delivery Systems Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Sustained Release Drug Delivery Systems Industry Trends
13.2 Sustained Release Drug Delivery Systems Market Drivers
13.3 Sustained Release Drug Delivery Systems Market Challenges
13.4 Sustained Release Drug Delivery Systems Market Restraints
14 Key Findings in The Global Sustained Release Drug Delivery Systems Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Sustained Release Drug Delivery Systems Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Nonbiodegradable Implants
Table 3. Major Manufacturers of Biodegradable Implants
Table 4. Major Manufacturers of Micro- and Nano-Particles
Table 5. Major Manufacturers of Liposomes
Table 6. Major Manufacturers of ECT
Table 7. Global Sustained Release Drug Delivery Systems Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Sustained Release Drug Delivery Systems Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 9. Global Sustained Release Drug Delivery Systems Sales by Region (2017-2022) & (Units)
Table 10. Global Sustained Release Drug Delivery Systems Sales Market Share by Region (2017-2022)
Table 11. Global Sustained Release Drug Delivery Systems Sales by Region (2023-2028) & (Units)
Table 12. Global Sustained Release Drug Delivery Systems Sales Market Share by Region (2023-2028)
Table 13. Global Sustained Release Drug Delivery Systems Revenue by Region (2017-2022) & (US$ Million)
Table 14. Global Sustained Release Drug Delivery Systems Revenue Market Share by Region (2017-2022)
Table 15. Global Sustained Release Drug Delivery Systems Revenue by Region (2023-2028) & (US$ Million)
Table 16. Global Sustained Release Drug Delivery Systems Revenue Market Share by Region (2023-2028)
Table 17. Global Sustained Release Drug Delivery Systems Sales by Manufacturers (2017-2022) & (Units)
Table 18. Global Sustained Release Drug Delivery Systems Sales Share by Manufacturers (2017-2022)
Table 19. Global Sustained Release Drug Delivery Systems Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 20. Global Sustained Release Drug Delivery Systems Revenue Share by Manufacturers (2017-2022)
Table 21. Sustained Release Drug Delivery Systems Price by Manufacturers (2017-2022) &(K USD/Unit)
Table 22. Global Sustained Release Drug Delivery Systems Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Sustained Release Drug Delivery Systems by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sustained Release Drug Delivery Systems as of 2021)
Table 24. Sustained Release Drug Delivery Systems Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Sustained Release Drug Delivery Systems Product Offered
Table 26. Date of Manufacturers Enter into Sustained Release Drug Delivery Systems Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Sustained Release Drug Delivery Systems Sales by Type (2017-2022) & (Units)
Table 29. Global Sustained Release Drug Delivery Systems Sales by Type (2023-2028) & (Units)
Table 30. Global Sustained Release Drug Delivery Systems Sales Share by Type (2017-2022)
Table 31. Global Sustained Release Drug Delivery Systems Sales Share by Type (2023-2028)
Table 32. Global Sustained Release Drug Delivery Systems Revenue by Type (2017-2022) & (US$ Million)
Table 33. Global Sustained Release Drug Delivery Systems Revenue by Type (2023-2028) & (US$ Million)
Table 34. Global Sustained Release Drug Delivery Systems Revenue Share by Type (2017-2022)
Table 35. Global Sustained Release Drug Delivery Systems Revenue Share by Type (2023-2028)
Table 36. Sustained Release Drug Delivery Systems Price by Type (2017-2022) & (K USD/Unit)
Table 37. Global Sustained Release Drug Delivery Systems Price Forecast by Type (2023-2028) & (K USD/Unit)
Table 38. Global Sustained Release Drug Delivery Systems Sales by Application (2017-2022) & (Units)
Table 39. Global Sustained Release Drug Delivery Systems Sales by Application (2023-2028) & (Units)
Table 40. Global Sustained Release Drug Delivery Systems Sales Share by Application (2017-2022)
Table 41. Global Sustained Release Drug Delivery Systems Sales Share by Application (2023-2028)
Table 42. Global Sustained Release Drug Delivery Systems Revenue by Application (2017-2022) & (US$ Million)
Table 43. Global Sustained Release Drug Delivery Systems Revenue by Application (2023-2028) & (US$ Million)
Table 44. Global Sustained Release Drug Delivery Systems Revenue Share by Application (2017-2022)
Table 45. Global Sustained Release Drug Delivery Systems Revenue Share by Application (2023-2028)
Table 46. Sustained Release Drug Delivery Systems Price by Application (2017-2022) & (K USD/Unit)
Table 47. Global Sustained Release Drug Delivery Systems Price Forecast by Application (2023-2028) & (K USD/Unit)
Table 48. North America Sustained Release Drug Delivery Systems Sales by Type (2017-2022) & (Units)
Table 49. North America Sustained Release Drug Delivery Systems Sales by Type (2023-2028) & (Units)
Table 50. North America Sustained Release Drug Delivery Systems Revenue by Type (2017-2022) & (US$ Million)
Table 51. North America Sustained Release Drug Delivery Systems Revenue by Type (2023-2028) & (US$ Million)
Table 52. North America Sustained Release Drug Delivery Systems Sales by Application (2017-2022) & (Units)
Table 53. North America Sustained Release Drug Delivery Systems Sales by Application (2023-2028) & (Units)
Table 54. North America Sustained Release Drug Delivery Systems Revenue by Application (2017-2022) & (US$ Million)
Table 55. North America Sustained Release Drug Delivery Systems Revenue by Application (2023-2028) & (US$ Million)
Table 56. North America Sustained Release Drug Delivery Systems Sales by Country (2017-2022) & (Units)
Table 57. North America Sustained Release Drug Delivery Systems Sales by Country (2023-2028) & (Units)
Table 58. North America Sustained Release Drug Delivery Systems Revenue by Country (2017-2022) & (US$ Million)
Table 59. North America Sustained Release Drug Delivery Systems Revenue by Country (2023-2028) & (US$ Million)
Table 60. Europe Sustained Release Drug Delivery Systems Sales by Type (2017-2022) & (Units)
Table 61. Europe Sustained Release Drug Delivery Systems Sales by Type (2023-2028) & (Units)
Table 62. Europe Sustained Release Drug Delivery Systems Revenue by Type (2017-2022) & (US$ Million)
Table 63. Europe Sustained Release Drug Delivery Systems Revenue by Type (2023-2028) & (US$ Million)
Table 64. Europe Sustained Release Drug Delivery Systems Sales by Application (2017-2022) & (Units)
Table 65. Europe Sustained Release Drug Delivery Systems Sales by Application (2023-2028) & (Units)
Table 66. Europe Sustained Release Drug Delivery Systems Revenue by Application (2017-2022) & (US$ Million)
Table 67. Europe Sustained Release Drug Delivery Systems Revenue by Application (2023-2028) & (US$ Million)
Table 68. Europe Sustained Release Drug Delivery Systems Sales by Country (2017-2022) & (Units)
Table 69. Europe Sustained Release Drug Delivery Systems Sales by Country (2023-2028) & (Units)
Table 70. Europe Sustained Release Drug Delivery Systems Revenue by Country (2017-2022) & (US$ Million)
Table 71. Europe Sustained Release Drug Delivery Systems Revenue by Country (2023-2028) & (US$ Million)
Table 72. Asia Pacific Sustained Release Drug Delivery Systems Sales by Type (2017-2022) & (Units)
Table 73. Asia Pacific Sustained Release Drug Delivery Systems Sales by Type (2023-2028) & (Units)
Table 74. Asia Pacific Sustained Release Drug Delivery Systems Revenue by Type (2017-2022) & (US$ Million)
Table 75. Asia Pacific Sustained Release Drug Delivery Systems Revenue by Type (2023-2028) & (US$ Million)
Table 76. Asia Pacific Sustained Release Drug Delivery Systems Sales by Application (2017-2022) & (Units)
Table 77. Asia Pacific Sustained Release Drug Delivery Systems Sales by Application (2023-2028) & (Units)
Table 78. Asia Pacific Sustained Release Drug Delivery Systems Revenue by Application (2017-2022) & (US$ Million)
Table 79. Asia Pacific Sustained Release Drug Delivery Systems Revenue by Application (2023-2028) & (US$ Million)
Table 80. Asia Pacific Sustained Release Drug Delivery Systems Sales by Region (2017-2022) & (Units)
Table 81. Asia Pacific Sustained Release Drug Delivery Systems Sales by Region (2023-2028) & (Units)
Table 82. Asia Pacific Sustained Release Drug Delivery Systems Revenue by Region (2017-2022) & (US$ Million)
Table 83. Asia Pacific Sustained Release Drug Delivery Systems Revenue by Region (2023-2028) & (US$ Million)
Table 84. Latin America Sustained Release Drug Delivery Systems Sales by Type (2017-2022) & (Units)
Table 85. Latin America Sustained Release Drug Delivery Systems Sales by Type (2023-2028) & (Units)
Table 86. Latin America Sustained Release Drug Delivery Systems Revenue by Type (2017-2022) & (US$ Million)
Table 87. Latin America Sustained Release Drug Delivery Systems Revenue by Type (2023-2028) & (US$ Million)
Table 88. Latin America Sustained Release Drug Delivery Systems Sales by Application (2017-2022) & (Units)
Table 89. Latin America Sustained Release Drug Delivery Systems Sales by Application (2023-2028) & (Units)
Table 90. Latin America Sustained Release Drug Delivery Systems Revenue by Application (2017-2022) & (US$ Million)
Table 91. Latin America Sustained Release Drug Delivery Systems Revenue by Application (2023-2028) & (US$ Million)
Table 92. Latin America Sustained Release Drug Delivery Systems Sales by Country (2017-2022) & (Units)
Table 93. Latin America Sustained Release Drug Delivery Systems Sales by Country (2023-2028) & (Units)
Table 94. Latin America Sustained Release Drug Delivery Systems Revenue by Country (2017-2022) & (US$ Million)
Table 95. Latin America Sustained Release Drug Delivery Systems Revenue by Country (2023-2028) & (US$ Million)
Table 96. Middle East and Africa Sustained Release Drug Delivery Systems Sales by Type (2017-2022) & (Units)
Table 97. Middle East and Africa Sustained Release Drug Delivery Systems Sales by Type (2023-2028) & (Units)
Table 98. Middle East and Africa Sustained Release Drug Delivery Systems Revenue by Type (2017-2022) & (US$ Million)
Table 99. Middle East and Africa Sustained Release Drug Delivery Systems Revenue by Type (2023-2028) & (US$ Million)
Table 100. Middle East and Africa Sustained Release Drug Delivery Systems Sales by Application (2017-2022) & (Units)
Table 101. Middle East and Africa Sustained Release Drug Delivery Systems Sales by Application (2023-2028) & (Units)
Table 102. Middle East and Africa Sustained Release Drug Delivery Systems Revenue by Application (2017-2022) & (US$ Million)
Table 103. Middle East and Africa Sustained Release Drug Delivery Systems Revenue by Application (2023-2028) & (US$ Million)
Table 104. Middle East and Africa Sustained Release Drug Delivery Systems Sales by Country (2017-2022) & (Units)
Table 105. Middle East and Africa Sustained Release Drug Delivery Systems Sales by Country (2023-2028) & (Units)
Table 106. Middle East and Africa Sustained Release Drug Delivery Systems Revenue by Country (2017-2022) & (US$ Million)
Table 107. Middle East and Africa Sustained Release Drug Delivery Systems Revenue by Country (2023-2028) & (US$ Million)
Table 108. West Pharmaceutical Services Corporation Information
Table 109. West Pharmaceutical Services Description and Major Businesses
Table 110. West Pharmaceutical Services Sustained Release Drug Delivery Systems Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
Table 111. West Pharmaceutical Services Sustained Release Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. West Pharmaceutical Services Recent Developments
Table 113. Cirtec Medical Corporation Information
Table 114. Cirtec Medical Description and Major Businesses
Table 115. Cirtec Medical Sustained Release Drug Delivery Systems Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
Table 116. Cirtec Medical Sustained Release Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Cirtec Medical Recent Developments
Table 118. Balda Corporation Information
Table 119. Balda Description and Major Businesses
Table 120. Balda Sustained Release Drug Delivery Systems Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
Table 121. Balda Sustained Release Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Balda Recent Developments
Table 123. Lubrizol Corporation Information
Table 124. Lubrizol Description and Major Businesses
Table 125. Lubrizol Sustained Release Drug Delivery Systems Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
Table 126. Lubrizol Sustained Release Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Lubrizol Recent Developments
Table 128. Beckman Coulter Corporation Information
Table 129. Beckman Coulter Description and Major Businesses
Table 130. Beckman Coulter Sustained Release Drug Delivery Systems Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
Table 131. Beckman Coulter Sustained Release Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Beckman Coulter Recent Developments
Table 133. Scios Corporation Information
Table 134. Scios Description and Major Businesses
Table 135. Scios Sustained Release Drug Delivery Systems Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
Table 136. Scios Sustained Release Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Scios Recent Developments
Table 138. Noven Pharmaceuticals Corporation Information
Table 139. Noven Pharmaceuticals Description and Major Businesses
Table 140. Noven Pharmaceuticals Sustained Release Drug Delivery Systems Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
Table 141. Noven Pharmaceuticals Sustained Release Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Noven Pharmaceuticals Recent Developments
Table 143. Raritan Pharmaceuticals Corporation Information
Table 144. Raritan Pharmaceuticals Description and Major Businesses
Table 145. Raritan Pharmaceuticals Sustained Release Drug Delivery Systems Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
Table 146. Raritan Pharmaceuticals Sustained Release Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Raritan Pharmaceuticals Recent Developments
Table 148. Parker Hannifin Corporation Information
Table 149. Parker Hannifin Description and Major Businesses
Table 150. Parker Hannifin Sustained Release Drug Delivery Systems Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
Table 151. Parker Hannifin Sustained Release Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. Parker Hannifin Recent Developments
Table 153. Nitto Avecia Pharma Services Corporation Information
Table 154. Nitto Avecia Pharma Services Description and Major Businesses
Table 155. Nitto Avecia Pharma Services Sustained Release Drug Delivery Systems Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
Table 156. Nitto Avecia Pharma Services Sustained Release Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. Nitto Avecia Pharma Services Recent Developments
Table 158. KV Pharmaceutical Corporation Information
Table 159. KV Pharmaceutical Description and Major Businesses
Table 160. KV Pharmaceutical Sustained Release Drug Delivery Systems Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
Table 161. KV Pharmaceutical Sustained Release Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
Table 162. KV Pharmaceutical Recent Developments
Table 163. Equashield Corporation Information
Table 164. Equashield Description and Major Businesses
Table 165. Equashield Sustained Release Drug Delivery Systems Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
Table 166. Equashield Sustained Release Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
Table 167. Equashield Recent Developments
Table 168. Shire Laboratories Corporation Information
Table 169. Shire Laboratories Description and Major Businesses
Table 170. Shire Laboratories Sustained Release Drug Delivery Systems Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
Table 171. Shire Laboratories Sustained Release Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
Table 172. Shire Laboratories Recent Developments
Table 173. Powder Systems Corporation Information
Table 174. Powder Systems Description and Major Businesses
Table 175. Powder Systems Sustained Release Drug Delivery Systems Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
Table 176. Powder Systems Sustained Release Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
Table 177. Powder Systems Recent Developments
Table 178. B. Braun OEM Division Corporation Information
Table 179. B. Braun OEM Division Description and Major Businesses
Table 180. B. Braun OEM Division Sustained Release Drug Delivery Systems Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
Table 181. B. Braun OEM Division Sustained Release Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
Table 182. B. Braun OEM Division Recent Developments
Table 183. Pharmaco-Kinesis Corporation Information
Table 184. Pharmaco-Kinesis Description and Major Businesses
Table 185. Pharmaco-Kinesis Sustained Release Drug Delivery Systems Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
Table 186. Pharmaco-Kinesis Sustained Release Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
Table 187. Pharmaco-Kinesis Recent Developments
Table 188. Foresee Corporation Information
Table 189. Foresee Description and Major Businesses
Table 190. Foresee Sustained Release Drug Delivery Systems Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
Table 191. Foresee Sustained Release Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
Table 192. Foresee Recent Developments
Table 193. Bayer Corporation Information
Table 194. Bayer Description and Major Businesses
Table 195. Bayer Sustained Release Drug Delivery Systems Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
Table 196. Bayer Sustained Release Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
Table 197. Bayer Recent Developments
Table 198. Catalent Corporation Information
Table 199. Catalent Description and Major Businesses
Table 200. Catalent Sustained Release Drug Delivery Systems Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
Table 201. Catalent Sustained Release Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
Table 202. Catalent Recent Developments
Table 203. Pfizer Corporation Information
Table 204. Pfizer Description and Major Businesses
Table 205. Pfizer Sustained Release Drug Delivery Systems Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
Table 206. Pfizer Sustained Release Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
Table 207. Pfizer Recent Developments
Table 208. Key Raw Materials Lists
Table 209. Raw Materials Key Suppliers Lists
Table 210. Sustained Release Drug Delivery Systems Distributors List
Table 211. Sustained Release Drug Delivery Systems Customers List
Table 212. Sustained Release Drug Delivery Systems Market Trends
Table 213. Sustained Release Drug Delivery Systems Market Drivers
Table 214. Sustained Release Drug Delivery Systems Market Challenges
Table 215. Sustained Release Drug Delivery Systems Market Restraints
Table 216. Research Programs/Design for This Report
Table 217. Key Data Information from Secondary Sources
Table 218. Key Data Information from Primary Sources
List of Figures
Figure 1. Sustained Release Drug Delivery Systems Product Picture
Figure 3. Global Sustained Release Drug Delivery Systems Market Share by Type in 2021 & 2028
Figure 3. Nonbiodegradable Implants Product Picture
Figure 4. Biodegradable Implants Product Picture
Figure 5. Micro- and Nano-Particles Product Picture
Figure 6. Liposomes Product Picture
Figure 7. ECT Product Picture
Figure 8. Global Sustained Release Drug Delivery Systems Market Share by Application in 2021 & 2028
Figure 9. Hospitals
Figure 10. Clinics
Figure 11. Others
Figure 12. Sustained Release Drug Delivery Systems Report Years Considered
Figure 13. Global Sustained Release Drug Delivery Systems Sales 2017-2028 (Units)
Figure 14. Global Sustained Release Drug Delivery Systems Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Sustained Release Drug Delivery Systems Revenue 2017-2028 (US$ Million)
Figure 16. Global Sustained Release Drug Delivery Systems Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 17. Global Sustained Release Drug Delivery Systems Sales Market Share by Region (2017-2022)
Figure 18. Global Sustained Release Drug Delivery Systems Sales Market Share by Region (2023-2028)
Figure 19. North America Sustained Release Drug Delivery Systems Sales YoY (2017-2028) & (Units)
Figure 20. North America Sustained Release Drug Delivery Systems Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Europe Sustained Release Drug Delivery Systems Sales YoY (2017-2028) & (Units)
Figure 22. Europe Sustained Release Drug Delivery Systems Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Asia-Pacific Sustained Release Drug Delivery Systems Sales YoY (2017-2028) & (Units)
Figure 24. Asia-Pacific Sustained Release Drug Delivery Systems Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Latin America Sustained Release Drug Delivery Systems Sales YoY (2017-2028) & (Units)
Figure 26. Latin America Sustained Release Drug Delivery Systems Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Middle East & Africa Sustained Release Drug Delivery Systems Sales YoY (2017-2028) & (Units)
Figure 28. Middle East & Africa Sustained Release Drug Delivery Systems Revenue YoY (2017-2028) & (US$ Million)
Figure 29. The Sustained Release Drug Delivery Systems Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 30. The Top 5 and 10 Largest Manufacturers of Sustained Release Drug Delivery Systems in the World: Market Share by Sustained Release Drug Delivery Systems Revenue in 2021
Figure 31. Global Sustained Release Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 32. Global Sustained Release Drug Delivery Systems Sales Market Share by Type (2017-2028)
Figure 33. Global Sustained Release Drug Delivery Systems Revenue Market Share by Type (2017-2028)
Figure 34. Global Sustained Release Drug Delivery Systems Sales Market Share by Application (2017-2028)
Figure 35. Global Sustained Release Drug Delivery Systems Revenue Market Share by Application (2017-2028)
Figure 36. North America Sustained Release Drug Delivery Systems Sales Market Share by Type (2017-2028)
Figure 37. North America Sustained Release Drug Delivery Systems Revenue Market Share by Type (2017-2028)
Figure 38. North America Sustained Release Drug Delivery Systems Sales Market Share by Application (2017-2028)
Figure 39. North America Sustained Release Drug Delivery Systems Revenue Market Share by Application (2017-2028)
Figure 40. North America Sustained Release Drug Delivery Systems Sales Share by Country (2017-2028)
Figure 41. North America Sustained Release Drug Delivery Systems Revenue Share by Country (2017-2028)
Figure 42. United States Sustained Release Drug Delivery Systems Revenue (2017-2028) & (US$ Million)
Figure 43. Canada Sustained Release Drug Delivery Systems Revenue (2017-2028) & (US$ Million)
Figure 44. Europe Sustained Release Drug Delivery Systems Sales Market Share by Type (2017-2028)
Figure 45. Europe Sustained Release Drug Delivery Systems Revenue Market Share by Type (2017-2028)
Figure 46. Europe Sustained Release Drug Delivery Systems Sales Market Share by Application (2017-2028)
Figure 47. Europe Sustained Release Drug Delivery Systems Revenue Market Share by Application (2017-2028)
Figure 48. Europe Sustained Release Drug Delivery Systems Sales Share by Country (2017-2028)
Figure 49. Europe Sustained Release Drug Delivery Systems Revenue Share by Country (2017-2028)
Figure 50. Germany Sustained Release Drug Delivery Systems Revenue (2017-2028) & (US$ Million)
Figure 51. France Sustained Release Drug Delivery Systems Revenue (2017-2028) & (US$ Million)
Figure 52. U.K. Sustained Release Drug Delivery Systems Revenue (2017-2028) & (US$ Million)
Figure 53. Italy Sustained Release Drug Delivery Systems Revenue (2017-2028) & (US$ Million)
Figure 54. Russia Sustained Release Drug Delivery Systems Revenue (2017-2028) & (US$ Million)
Figure 55. Asia Pacific Sustained Release Drug Delivery Systems Sales Market Share by Type (2017-2028)
Figure 56. Asia Pacific Sustained Release Drug Delivery Systems Revenue Market Share by Type (2017-2028)
Figure 57. Asia Pacific Sustained Release Drug Delivery Systems Sales Market Share by Application (2017-2028)
Figure 58. Asia Pacific Sustained Release Drug Delivery Systems Revenue Market Share by Application (2017-2028)
Figure 59. Asia Pacific Sustained Release Drug Delivery Systems Sales Share by Region (2017-2028)
Figure 60. Asia Pacific Sustained Release Drug Delivery Systems Revenue Share by Region (2017-2028)
Figure 61. China Sustained Release Drug Delivery Systems Revenue (2017-2028) & (US$ Million)
Figure 62. Japan Sustained Release Drug Delivery Systems Revenue (2017-2028) & (US$ Million)
Figure 63. South Korea Sustained Release Drug Delivery Systems Revenue (2017-2028) & (US$ Million)
Figure 64. India Sustained Release Drug Delivery Systems Revenue (2017-2028) & (US$ Million)
Figure 65. Australia Sustained Release Drug Delivery Systems Revenue (2017-2028) & (US$ Million)
Figure 66. Taiwan Sustained Release Drug Delivery Systems Revenue (2017-2028) & (US$ Million)
Figure 67. Indonesia Sustained Release Drug Delivery Systems Revenue (2017-2028) & (US$ Million)
Figure 68. Thailand Sustained Release Drug Delivery Systems Revenue (2017-2028) & (US$ Million)
Figure 69. Malaysia Sustained Release Drug Delivery Systems Revenue (2017-2028) & (US$ Million)
Figure 70. Latin America Sustained Release Drug Delivery Systems Sales Market Share by Type (2017-2028)
Figure 71. Latin America Sustained Release Drug Delivery Systems Revenue Market Share by Type (2017-2028)
Figure 72. Latin America Sustained Release Drug Delivery Systems Sales Market Share by Application (2017-2028)
Figure 73. Latin America Sustained Release Drug Delivery Systems Revenue Market Share by Application (2017-2028)
Figure 74. Latin America Sustained Release Drug Delivery Systems Sales Share by Country (2017-2028)
Figure 75. Latin America Sustained Release Drug Delivery Systems Revenue Share by Country (2017-2028)
Figure 76. Mexico Sustained Release Drug Delivery Systems Revenue (2017-2028) & (US$ Million)
Figure 77. Brazil Sustained Release Drug Delivery Systems Revenue (2017-2028) & (US$ Million)
Figure 78. Argentina Sustained Release Drug Delivery Systems Revenue (2017-2028) & (US$ Million)
Figure 79. Colombia Sustained Release Drug Delivery Systems Revenue (2017-2028) & (US$ Million)
Figure 80. Middle East and Africa Sustained Release Drug Delivery Systems Sales Market Share by Type (2017-2028)
Figure 81. Middle East and Africa Sustained Release Drug Delivery Systems Revenue Market Share by Type (2017-2028)
Figure 82. Middle East and Africa Sustained Release Drug Delivery Systems Sales Market Share by Application (2017-2028)
Figure 83. Middle East and Africa Sustained Release Drug Delivery Systems Revenue Market Share by Application (2017-2028)
Figure 84. Middle East and Africa Sustained Release Drug Delivery Systems Sales Share by Country (2017-2028)
Figure 85. Middle East and Africa Sustained Release Drug Delivery Systems Revenue Share by Country (2017-2028)
Figure 86. Turkey Sustained Release Drug Delivery Systems Revenue (2017-2028) & (US$ Million)
Figure 87. Saudi Arabia Sustained Release Drug Delivery Systems Revenue (2017-2028) & (US$ Million)
Figure 88. UAE Sustained Release Drug Delivery Systems Revenue (2017-2028) & (US$ Million)
Figure 89. Sustained Release Drug Delivery Systems Value Chain
Figure 90. Sustained Release Drug Delivery Systems Production Process
Figure 91. Channels of Distribution
Figure 92. Distributors Profiles
Figure 93. Bottom-up and Top-down Approaches for This Report
Figure 94. Data Triangulation
Figure 95. Key Executives Interviewed

以下、関連資料のご紹介

注射用薬物送達システムのグローバル市場インサイト・予測（～2028年）

Global Injectable Drug Delivery Systems Market Insights, Forecast to 2028
QY2203B12156 2022年3月 109Pages
新型コロナウイルス感染症のパンデミックにより、世界の注射用薬物送達システムの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に注射用薬物送達...

麻酔デリバリーマシンのグローバル市場インサイト・予測（～2028年）

Global Anesthesia Delivery Machines Market Insights and Forecast to 2028
QY2203B13846 2022年3月 114Pages
新型コロナウイルス感染症のパンデミックにより、世界の麻酔デリバリーマシンの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に麻酔デリバリーマ...

内視鏡的軟部組織リリースシステムのグローバル市場インサイト・予測（～2028年）

Global Endoscopic Soft Tissue Release System Market Insights, Forecast to 2028
QY2203B12939 2022年3月 110Pages
新型コロナウイルス感染症のパンデミックにより、世界の内視鏡的軟部組織リリースシステムの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に内視...

フィブリノゲン欠乏症治療薬のグローバル市場インサイト・予測（～2028年）

Global Fibrinogen Deficiency Drug Market Insights and Forecast to 2028
QY2203B05315 2022年3月 99Pages
新型コロナウイルス感染症のパンデミックにより、世界のフィブリノゲン欠乏症治療薬の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にフィブリノ...

植物薬のグローバル市場インサイト・予測（～2028年）

Global Botanical Drug Market Insights and Forecast to 2028
QY2203B11006 2022年3月 119Pages
新型コロナウイルス感染症のパンデミックにより、世界の植物薬の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に植物薬の世界市場のxxx％を占...

膵臓内分泌腫瘍（PNET）治療薬のグローバル市場インサイト・予測（～2028年）

Global Pancreatic Endocrine Tumor Drug Market Insights and Forecast to 2028
QY2203B14340 2022年3月 90Pages
新型コロナウイルス感染症のパンデミックにより、世界の膵臓内分泌腫瘍（PNET）治療薬の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に膵臓...

油圧クイックリリースカップリングのグローバル市場インサイト・予測（～2028年）

Global Hydraulic Quick Release Couplings Market Insights, Forecast to 2028
QY2203B14022 2022年3月 125Pages
新型コロナウイルス感染症のパンデミックにより、世界の油圧クイックリリースカップリングの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に油圧...

転移性メラノーマ治療薬のグローバル市場インサイト・予測（～2028年）

Global Metastatic Melanoma Drug Market Insights and Forecast to 2028
QY2203B12437 2022年3月 107Pages
新型コロナウイルス感染症のパンデミックにより、世界の転移性メラノーマ治療薬の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に転移性メラノ...

リポソームドラッグデリバリーのグローバル市場 2021年：企業別、地域別、種類・用途別

Global Liposome Drug Delivery Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-203B16206 2021年12月 96Pages
リポソームドラッグデリバリー市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提...

小型骨固定装置のグローバル市場インサイト・予測（～2028年）

Global Small Bone Fixation Systems Market Insights and Forecast to 2028
QY2203B10870 2022年3月 90Pages
新型コロナウイルス感染症のパンデミックにより、世界の小型骨固定装置の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に小型骨固定装置の世界市...

注射用薬物送達システムのグローバル市場インサイト・予測（～2028年） Injectable drug delivery is defined as introduction of a drug or drugs in the patient by using a delivery device. Injectables allow the transport of drugs formulated in liquid form, directly in the body. Even though, they may be designed to transport the drug to specific part of the body. Market Ana…
麻酔デリバリーマシンのグローバル市場インサイト・予測（～2028年） An anesthesia delivery machine is designed to deliver drugs to patients to help eliminate pain and other unwanted sensations. the continuous flow anesthetic machine provides an accurate and constant supply of medical gases (such as air, oxygen, and nitrous oxide), mixed with an accurate concentratio…
リポソームドラッグデリバリーのグローバル市場 2021年：企業別、地域別、種類・用途別 The Liposome Drug Delivery market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulati…
油圧クイックリリースカップリングのグローバル市場インサイト・予測（～2028年） Quick release couplings are fitting are used to mate fluid lines with system equipment that requires frequent connecting and disconnecting. They are used in both pneumatic and hydraulic applications to build or discontinue the connection of a fluid pipeline. Market Analysis and Insights: Global Hyd…
超高純度ガス供給システムのグローバル市場 2021年：企業別、地域別、種類・用途別 The Ultra High Purity Gas Delivery Systems market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization…